Browse By: Country ι Category ι Publisher ι Tag

Discovery, Preclinical and Clinical Stage Partnering Terms and Agreements in Pharma and Biotech

Pages » 1749
Published By » Current Partnering
Price » $5495
In stock
View Report Details
Description

The Discovery, Preclinical and Clinical Stage Partnering Terms and Agreements in Pharma and Biotech report provides comprehensive understanding and unprecedented access to the discovery, preclinical and clinical stage partnering deals and agreements entered into by the worlds leading healthcare companies.   The report provides a detailed understanding and analysis of how and why companies enter discovery, preclinical and clinical stage partnering deals. The majority of deals are where the licensee obtains a right or an option right to license the licensors product or compound. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcom... Click here for more details


Bioinformatics Partnering Terms and Agreements
The Bioinformatics Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access tthe bioinformatics partnering deals and agreements entered intby the worlds leading healthcare companies. Trends in bioinformatics partnering deals Deal terms analysis
Published Date: Sep 2013
Price: $2995
Vaccine Partnering Terms and Agreements
The Vaccine Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the vaccine partnering deals and agreements entered into by the worlds leading healthcare companies.   Trends in vaccine and adjuvant partnering deals Deal terms an
Published Date: Jul 2014
Price: $2995
Co-promotion and Co-marketing Agreements in Pharma, Biotech and Diagnostics, 5th edition
The Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the co-promotion and co-marketing partnering agreements entered into by the worlds leading biopharma companies. This rep
Published Date: Jul 2011
Price: $2995
Pharmacogenomic Partnering Terms and Agreements
The Pharmacogenomic Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the pharmacogenomic partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding and analy
Published Date: Apr 2011
Price: $2695
Biomarker Partnering Terms and Agreements
The Biomarker Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the biomarker partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in biomarker partnering deals Biomarker partnering a
Published Date: Nov 2014
Price: $2995
Companion Diagnostics Partnering Terms & Agreements
The Companion Diagnostics Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the companion diagnostics partnering deals and agreements entered into by the worlds leading healthcare companies.   The report provides a detailed und
Published Date: Nov 2014
Price: $1995
Partnering Terms and Agreements in Diagnostics, 2nd edition
The Partnering Terms and Agreements in Diagnostics report provides comprehensive understanding and unprecedented access to the diagnostic partnering agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding and analysis of how and
Published Date: Nov 2010
Price: $2695
Discovery Stage Partnering Terms and Agreements in Pharma, Biotech and Diagnostics
The Discovery Stage Partnering Terms and Agreements in Pharma and Biotech report detailed understanding and analysis of how and why companies enter discovery stage licensing/business development and other forms of partnering arrangement. The report provides a detailed understanding and anal
Published Date: Jun 2010
Price: $2695
Option and Evaluation Partnering Terms and Agreements in Pharma, Biotech and Diagnostics
The Option and Evaluation Partnering Terms and Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the option and evaluation partnering agreements entered into by the worlds leading biopharma companies.   The report p
Published Date: Nov 2014
Price: $2995
Pre-clinical Stage Partnering Terms & Agreements in Pharma, Biotech & Diagnostics
The Pre-clinical Stage Partnering Terms and Agreements in Pharma, Biotech and Diagnostics report detailed understanding and analysis of how and why companies enter pre-clinical stage licensing/business development and other forms of partnering arrangement. The report provides a detailed under
Published Date: Jun 2010
Price: $2695

 


 

Related News

New Innovations in Optics LED
New innovations in the field of lasers and optics have introduced high density white LED light engines for OEM fiber optic illumination. White light LEDs are rapidly becoming the most preferred source for light guide illumination in several technical applications which were once ruled by HID lamps and tungsten halogen. White LEDs offer operational advantages and substantial cost. LumiBright™ delivers up to 4000 lumens into the light guide. LumiBright have no additional optics and couple
Date: Dec 18

‘Fluctuations in Air Freight Impacts Pharma Supply Chains’
Air freight has been considered to be imperative to the pharmaceutical industry more so as supply chains take on a more complex shape. The Life Science and Pharmaceutical conference held in London on Tuesday stressed upon this very fact. Emerging trends such as healthcare at home, increasing clinical trials across the globe, and advanced therapies as well as companion diagnostics have tremendously changed the pharmaceutical industry, according to David Spillet, key account director at World C
Date: Dec 17

Two AC/DC Drivers Launched by ON
On Semiconductor has recently expanded their product line for NCL3008x by launching two new series of offline AC-DC drivers with Power Factor Correction. Their new line of semiconductors includes the new NCL30085/86/88/30. The NCL30030 widens the existing solutions which support higher power topologies. Their primary purpose would be in high performance LED lighting applications. The new line of PFC drivers are said to be small, robust, and flexible. Three of them use a PF corrected algorithm
Date: Dec 17

Different Prospects of New Nuclear Power
Nuclear energy was once promised as the world’s leading source to provide cheap and safe electrical power. However, The United States has led the way in nuclear research due to government finance and support. Some analysts also claimed that electricity would go meterless in the future.   Nevertheless, things did not turn out as decided due to nuclear waste accumulation, accidents, and safety problems, and most of all – rising costs. Despite these problems, growth in nuclear p
Date: Dec 17

Drop in Oil Prices sets off Alarm Bells in Producers and Shareholders
The well-publicized drop in oil prices this week has been celebrated by the masses all over the world as an answer to years of demands. However, the picture is far from rosy on the other side, as oil exporters and shareholders reacquaint themselves with a sub-$60 per-barrel pricing after a considerable hiatus. Increasing amounts of oil production from countries outside the OPEC (Organization of the Petrol Exporting Countries) is loosening OPEC’s stranglehold over the global petroleum ma
Date: Dec 16

Chinese Construction Shares Rise on Stimulus Bets
For the second consecutive day, China’s stocks have risen, led by railway and construction companies. Their growth has been based on the speculation that the government will take improved steps to support economic growth. China Railway Group Ltd. and China State Construction Engineering Corp. gained more than 7 per cent, enough to lead the rise for infrastructure related companies. Meanwhile, Premier Li Keqiang is visiting Kazakhstan to forge a Silk Road Fund that could finance the buil
Date: Dec 15

Citigroup Charges Investors with US$2.7 Billion for Legal Expenses
Citigroup gave its investors a surprise with its 4th quarter results on Tuesday, with an expected US$2.7 billion legal charge associated with multiple investigations. Citigroup has been discussing for settlement with banking regulators and federal prosecutors over a series of investigations connected to possible manipulation in the lax anti-money-laundering controls and the currency market. The 4th quarter charge also reveals the expected cost of a separate inquiry about the role Citigroup an
Date: Dec 10

After Louisiana-Pacific’s Downgrade - What’s next in the Building and Construction Products Industry?
Louisiana-Pacific Corporation was downgraded by the DA Davidson research firm last Friday from a status of “Buy” to a “Neutral” rating, i.e. LPX 0%. RBC Capital had struck a similar rating a few days earlier. It changed its rating from ‘Sector Perform’ to ‘Underperform’ - where the price target was set as $13.00 per share. These implications apply a downside potential of 22 percent from the present price (as of December 8) of $16.85 per share. 
Date: Dec 09

Southern Company Got Warning from State Monitor on Ga. Nuclear Plant Costs
State monitors has warned Southern Co. that building a multi-billion dollar nuclear plant in Georgia without having a comprehensive construction schedule could cause financial penalties. A report was filed by an analyst and an engineer working for state regulators. They supervise the elevation of two new reactors situated at Plant Vogtle in eastern Georgia. The warning was mentioned in that report. The Public Service Commission has notified for at least two years that Georgia Power, a subs
Date: Dec 08

India to Export Carabeef to Russia
According to some recent talks between India’s (APEDA) and phyto-sanitary watchdog Rosselkhoznadzor, Russia has permitted the imports of buffalo meat (carabeef) from India.  This act falls under the Ministry of Commerce and Industry of India. The move is placed a few days ahead of the Russian President’s visit to India. Rosselkhoznadzor in association with the Ministry of Agriculture of Kazakhstan has involved Indian exporters on its buffalo meat import list.  Compani
Date: Dec 08

Upcoming Reports

Acute Myeloid Leukemia (AML) Therapeutics Market - Global Industry Size, Market Share, Trends, Analysis And Forecasts, 2012 - 2018
Acute myeloid leukemia grows at a fast pace and is found in the blood and bone marrow. The leukemia therapeutics market is divided into four segments namely acute lymphocytic leukemia, acute myeloid leukemia, chronic lymphocytic leukemia and chronic myeloid leukemia. In the disease process, imma
Published By: Transparency Market Research
Price: $4795
Antibiotic Market - Global Industry Size, Share, Trends, Analysis And Forecast, 2012 - 2018
An antibiotic is a compound or a substance that fights bacterial infections and kills or slow down their growth. The antibiotic market is witnessing high growth due new product innovations and higher investment in R & D activity. Moreover, the other regulatory concerns to control the antibioti
Published By: Transparency Market Research
Price: $4795
Next Generation Sequencers Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
Next generation sequencers are used inthe sequencing technologies which massively parallelize the DNA sequencing process rather than being limited to single or few fragments of DNA. The next generation sequencing (NGS) technology enables rapid sequencing and produce thousands and millions of seque
Published By: Transparency Market Research
Price: $4795
Rheumatoid Arthritis Pharmacotherapeutics Market - Global Industry Size, Market Share, Trends, Analysis And Forecast, 2012 - 2018
Treatment options for rheumatoid arthritis (RA) are expanding as a result of increasing research activities and more explicit understanding of the pathophysiology of diseases. For the treatment of RA, novel selective inhibitors such as cyclooxygenase-2 (COX-2) are used along with the non-steroidal
Published By: Transparency Market Research
Price: $4795
Prenatal Diagnostics Market - Global Industry Size, Market Share, Trends, Analysis And Forecast, 2012 - 2018
Prenatal diagnostics is a procedure for testing of diseases before the birth of a child, to determine certain inheritable disorders such as chromosome abnormalities, Down’s syndrome, genetic diseases, neural tube defects, and other conditions. It can be conducted by various procedures of scr
Published By: Transparency Market Research
Price: $4795
Pediatric Vaccines Market - Global Industry Analysis, Market Size, Market Share And Forecasts, 2012 - 2018
The global pediatric vaccine market is forecasted to reach $24.3 billion by the year 2017 at a compounded annual growth rate of 11.5 % during 2011-2017. This growth in revenues is expected to be driven by the introduction of new molecules that are currently in regulatory filing stage and those i
Published By: Transparency Market Research
Price: $4795
Dermatological Diagnostics And Therapeutics Market - Global Industry Analysis, Market Size, Market Share And Forecasts, 2012 - 2018
The Dermatological diagnostics and therapeutics market is expected to grow steadily during the forecast period driven by increase in psoriasis market that is expected to boost competition among the existing products with more emerging therapies. Acne is the largest market segment of the dermatolog
Published By: Transparency Market Research
Price: $4795
Hepatitis C Market - Global Industry Size, Share, Trends, Analysis And Forecasts 2012 - 2018
The world market for HCV drugs represents an area of potential opportunities in developed as well as developing countries. Because of the technological advancements and effectiveness, many big market players are focusing on development of innovative drugs for HCV. Major companies are forming coali
Published By: Transparency Market Research
Price: $4795
EPharmacies Market - Global Industry Size, Market Share, Trends, Analysis, And Forecasts 2012 - 2018
The global market for ePharmacies is projected to reach USD 51.75 billion by the end of 2017 owing to the increasing number of tech-savvy people and rising demand for prescription drugs. The ePharmacies meeting the regulatory standards set by the government and following ethical business practices
Published By: Transparency Market Research
Price: $4795
Congestive Heart Failure Treatment Devices Market - Global Industry Size, Share, Trends, Analysis And Forecasts 2012 - 2018
The global market for congestive heart failure treatment devices is expected to reach $5.9 billion by the year 2016 at the compounded annual growth rate of 11.7% during the forecasted period. This growth is mainly attributed by the rising incidences of heart failures across the world. American mar
Published By: Transparency Market Research
Price: $4795